NDAVAGINALRING
Approved
Aug 2018
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
6/8 — Strong
ANNOVERA (segesterone acetate and ethinyl estradiol) by Mayne Pharma is estrogen receptor agonists [moa]. Approved for pregnancy. First approved in 2018.
Drug data last refreshed 2h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ANNOVERA is a vaginal contraceptive ring containing segesterone acetate and ethinyl estradiol, approved in 2018 for pregnancy prevention. It works as an estrogen receptor agonist to prevent ovulation and is designed for extended-cycle use with a one-year duration per ring. The product represents an innovative non-daily contraceptive option for women seeking long-acting reversible birth control.
$0.111MPart D
Peak12.7 years to LOEProduct is in peak commercial phase with low Medicare Part D penetration, suggesting significant upside opportunity in patient education and access expansion initiatives.
Mechanism of Action
Estrogen Receptor Agonists
Pharmacologic Class:
Estrogen
Indications (1)
Career Relevance
ANNOVERA roles focus on expanding awareness and adoption in the women's health/contraception market, with emphasis on reimbursement navigation and patient access given low current Part D penetration (45 claims in 2023). Career growth opportunities exist in building market share against generic alternatives and NUVARING's approaching LOE, with potential to establish ANNOVERA as the market-leading annual ring.
Worked on ANNOVERA at Mayne Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.